4 nov 2020
CPhI South East Asia 2020
Jiangsu Hengrui Medicine Co., Ltd

Jiangsu Hengrui Medicine Co., Ltd

Exhibitor at CPhI South East Asia 2020 stand 6.923

About us

     Hengrui Medicine is a leading pharmaceutical company based in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. Hengrui was established in 1970 and listed in Shanghai Stock Exchange in 2000. The company ranks top 30 worldwide in pharmaceuticals industry by a market capitalization of over 30 billion USD, and is home to more than 21,000 employees worldwide. Hengrui not only stands out as a front-runner in cancer drugs, contrast agents, and surgical medicines, but is also a lead member of the National Anti-Tumor Medicine Technology Innovation Industry-Education-Research Alliance. Hengrui owns a National Targeted Drug Engineering Technology Research Center, and a post-doctoral research station. In May 2018, Hengrui Medicine was listed in Forbes’s top 100 world’s most innovative companies and ranked the 64th, where only 7 companies from China were on the list.      Hengrui fully owns 8 manufacturing facilities for small and large molecules as well as medical devices. All facilities are approved and audited by NMPA, most also approved by US FDA, EDQM, TGA, and PMDA.      Embracing the spirit of “Honesty and Trustworthiness, Quality First” as a business principle, Hengrui leads the Chinese markets for anti-cancer drugs, surgical anesthetics, specialized infusions, and contrast agents. To date, Hengrui has 10+ products approved in Europe, US, and Japan, covering injectables, oral formulations, and inhalational anesthetics, and has achieved remarkable sales in those markets. Pursuing the concept of “Excelling in Science, Enhancing Life”, Hengrui sees its future as a Chinese multi-national pharmaceutical corporation, and continuously strives for innovation, progress, and achievement of new breakthrough in the healthcare industry.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: APIs |Finished Dosage Forms |Injectables More

Products featured at CPhI South East Asia 2020

Categories affiliated with Jiangsu Hengrui Medicine Co., Ltd

Jiangsu Hengrui Medicine Co., Ltd

Event information

CPhI South East Asia 2020

4 - 6 November 2020 Bangkok, Thailand Visit us at stand 6.923